# A Study on the Clinical Course, Outcomes and Risk Factors of Myocarditis and Pericarditis After Moderna COVID-19 Vaccine

> **NCT06113692** · — · COMPLETED · sponsor: **ModernaTX, Inc.** · enrollment: 1169 (actual)

## Conditions studied

- Myocarditis, Pericarditis

## Interventions

- **BIOLOGICAL:** mRNA-1273

## Key facts

- **NCT ID:** NCT06113692
- **Lead sponsor:** ModernaTX, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-31
- **Primary completion:** 2024-08-31
- **Final completion:** 2025-06-30
- **Target enrollment:** 1169 (ACTUAL)
- **Last updated:** 2025-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06113692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06113692, "A Study on the Clinical Course, Outcomes and Risk Factors of Myocarditis and Pericarditis After Moderna COVID-19 Vaccine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06113692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*